Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading ...
Venus Remedies secures EU GMP renewal from Infarmed, strengthens European market presence: Our Bureau, Bengaluru Wednesday, January 22, 2025, 15:30 Hrs [IST] Venus Remedies has an ...
Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...
Venus Remedies secures renewed EU GMP certification for its manufacturing facility, enabling expansion in European and global ...
The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...
The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...
eVnExpress on MSN10d
Imexpharm achieves VND2,205 billion in net revenue in 2024Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback